May 19
💊 Roche & Medicines Patent Pool Expand Access to Influenza Treatment 🌍
Roche and Medicines Patent Pool have signed a licensing agreement to expand access to the influenza antiviral drug Xofluza across 129 low- and middle-income countries.
The partnership will support affordable generic production, improve outbreak preparedness, and strengthen global healthcare access.
✔️ WHO-recommended treatment ✔️ Expanded access in 129 countries ✔️ Stronger pandemic preparedness
📌 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐏 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 𝐆𝐫𝐨𝐮𝐩 𝐅𝐨𝐫 𝐚 𝐅𝐫𝐞𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐈𝐏 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐥𝐞𝐠𝐚𝐥 𝐠𝐮𝐢𝐝𝐚𝐧𝐜𝐞: 📧 [email protected] 🌐 www.ipconsultinggroups.com